Schizophrenia Research
Volume 58, Issue 1 , Pages 83-86 , 1 November 2002

Polymorphism analysis of the upstream region of the human N-methyl-d-aspartate receptor subunit NR1 gene (GRIN1): implications for schizophrenia

  • Ayako Tani

      Affiliations

    • Division of Disease Genes, Research Center for Genetic Information, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashiku, Fukuoka 812-8582, Japan
    • ,
  • Rumiko Kikuta

      Affiliations

    • Division of Disease Genes, Research Center for Genetic Information, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashiku, Fukuoka 812-8582, Japan
    • ,
  • Kanako Itoh

      Affiliations

    • Division of Disease Genes, Research Center for Genetic Information, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashiku, Fukuoka 812-8582, Japan
    • ,
  • Akiko Joo

      Affiliations

    • Division of Disease Genes, Research Center for Genetic Information, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashiku, Fukuoka 812-8582, Japan
    • ,
  • Hiroki Shibata

      Affiliations

    • Division of Disease Genes, Research Center for Genetic Information, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashiku, Fukuoka 812-8582, Japan
    • ,
  • Hideaki Ninomiya

      Affiliations

    • Fukuoka Prefectural Dazaifu Hospital Psychiatric Center, Dazaifu, Japan
    • ,
  • Nobutada Tashiro

      Affiliations

    • Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    • ,
  • Yasuyuki Fukumaki

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +81-92-642-6167; fax: +81-92-632-2375
    • Division of Disease Genes, Research Center for Genetic Information, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashiku, Fukuoka 812-8582, Japan

Received 15 July 2001 ,Accepted 29 December 2001.

References 

  1. Akbarian S, Sucher NJ, Bradley D, Tafazzoli A, Trinh D, Hetrick WP, et al. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J. Neurosci. 1996;16:19–30
  2. Bai G, Kusiak JW. Functional analysis of the proximal 5′-flanking region of the N-methyl-d-aspartate receptor subunit gene, NMDAR1. J. Biol. Chem. 1995;270:7737–7744
  3. Bannai M, Tokunaga K, Lin L, Kuwata S, Mazda T, Amaki I, et al. Discrimination of human HLA-DRB1 alleles by PCR-SSCP (single-strand conformation polymorphism) method. Eur. J. Immunogenet. 1994;21:1–9
  4. Bliss TVP, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 1993;361:31–39
  5. Choi DW, Koh JY, Peters S. Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J. Neurosci. 1988;8:185–196
  6. Crosby SD, Puetz JJ, Simburger KS, Fahrner TJ, Milbrandt J. The early response gene NGFI-C encodes a zinc finger transcriptional activator and is a member of the GCGGGGGCG (GSG) element-binding protein family. Mol. Cell Biol. 1991;11:3835–3841
  7. Gao XM, Sakai K, Roberts RC, Conley RR, Dean B, Tamminga CA. Ionotropic glutamate receptors and expression of N-methyl-d-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am. J. Psychiatry. 2000;157:1141–1149
  8. Goff DC, Wine L. Glutamate in schizophrenia: clinical and research implications. Schizophr. Res. 1997;27:157–168
  9. Humphries C, Mortimer A, Hirsch S, de Belleroche J. NMDA receptor mRNA correlation with antemortem cognitive impairment in schizophrenia. NeuroReport. 1996;7:2051–2055
  10. Ibrahim HM, Hogg AJ, Healy DJ, Haroutunian V, Davis KL, Meador-Woodruff JH. Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia. Am. J. Psychiatry. 2000;157:1811–1823
  11. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry. 1991;148:1301–1308
  12. Joo A, Shibata H, Ninomiya H, Kawasaki H, Tashiro N, Fukumaki Y. Structure and polymorphisms of the human metabotropic glutamate receptor type 2 gene (GRM2): analysis of association with schizophrenia. Mol. Psychiatry. 2001;6:186–192
  13. Kutsuwada T, Kashiwabuchi N, Mori H, Sakimura K, Kushiya E, Araki K, et al. Molecular diversity of the NMDA receptor channel. Nature. 1992;358:36–41
  14. Lania L, Majello B, De Luca P. Transcriptional regulation by the Sp family proteins. Int. J. Biochem. Cell Biol. 1997;29:1313–1323
  15. Lipton SA, Kater SB. Neurotransmitter regulation of neuronal outgrowth, plasticity, and survival. Trends Neurosci. 1989;12:265–270
  16. Luby ED, Cohen BD, Rosenbaum F, Gottlieb J, Kelly R. Study of a new schizophrenomimetic drug, Sernyl. AMA Arch. Neurol. Psychiatry. 1959;81:363–369
  17. Mohn AR, Gainetdinov RR, Caron MG, Koller BH. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell. 1999;20:427–436
  18. Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, et al. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science. 1992;256:1217–1221
  19. Rice SR, Niu N, Berman DB, Heston LL, Sobell JL. Identification of single nucleotide polymorphisms (SNPs) and other sequence changes and estimation of nucleotide diversity in coding and flanking regions of the NMDAR1 receptor gene in schizophrenic patients. Mol. Psychiatry. 2001;6:274–284
  20. Risch NJ. Searching for genetic determinants in the new millennium. Nature. 2000;405:847–856
  21. Sakurai K, Toru M, Yamakawa-Kobayashi K, Arinami T. Mutation analysis of the N-methyl-d-aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia. Neurosci. Lett. 2000;296:168–170

PII: S0920-9964(02)00161-5

Schizophrenia Research
Volume 58, Issue 1 , Pages 83-86 , 1 November 2002

Article Tools